November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT
Oct 23, 2023, 15:35

Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT

Julien Mazières, Thoracic Oncology Specialist at Toulouse University Hospital, France, shared insights from the ALINA study from ESMO23 on X/Twitter:

“Another big hit ESMO 23. Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT. Impressive curves and HR 0.24. Immediate practice-changing trial.”

Julien Mazières: Alectinib is the first ALK inhibitor to significantly improve DFS compared with CT

Source: Julien Mazières/Twitter.